[ Price : $8.95]
FDA publishes the latest CDER guidance agenda showing plans for 85 new or revised guidances to be issued in 2026.[ Price : $8.95]
FDA approves Merck's Lipfendra (enlicitide) 20 mg tablets as an adjunct to diet and exercise to reduce low-density lipoprotein cho...[ Price : $8.95]
Kalshi launches a pilot program allowing traders to buy and sell contracts tied to the outcomes of late-stage clinical trials and ...[ Price : $8.95]
FDA warns Irvine, CA-based Nihon Kohden Digital Health Solutions that it is marketing an adulterated and misbranded unapproved med...[ Price : $8.95]
Witnesses at a House Energy and Commerce Health Subcommittee hearing urge lawmakers to modernize the nation's clinical trial syste...[ Price : $8.95]
House Energy and Commerce Health Subcommittee leaders reveal differing views over whether the Trump administration's policies are ...[ Price : $8.95]
FDA acting commissioner Kyle Diamantas positions the agencys four public health pillars as a means to fulfill its enduring mission...[ Price : $8.95]
A Cancer Network post says FDA issued a voluntary action indicated close-out letter to HLB following a CGMP inspection at a facili...